Disruption of metabolic, sleep, and sensorimotor functional outcomes in a female transgenic mouse model of Alzheimer's disease.
Alzheimer's Disease (AD) is the most prevalent form of dementia globally, and the number of individuals with AD diagnosis is expected to double by 2050. Numerous preclinical AD studies have shown that AD neuropathology accompanies alteration in learning and memory. However, less attention has been given to alterations in metabolism, sleep, and sensorimotor functional outcomes during AD pathogenesis. The objective of this study was to elucidate the extent to which metabolic activity, sleep-wake cycle, and sensorimotor function is impaired in APPSwDI/Nos2-/- (CVN-AD) transgenic mice. Female mice were used in this study because AD is more prevalent in women compared to men. We hypothesized that the presence of AD neuropathology in CVN-AD mice would accompany alterations in metabolic activity, sleep, and sensorimotor function. Our results showed that CVN-AD mice had significantly decreased energy expenditure compared to wild-type (WT) mice. An examination of associated functional outcome parameters showed that sleep activity was elevated during the awake (dark) cycle and as well as an overall decrease in spontaneous locomotor activity. An additional functional parameter, the nociceptive response to thermal stimuli, was also impaired in CVN-AD mice. Collectively, our results demonstrate CVN-AD mice exhibit alterations in functional parameters that resemble human-AD clinical progression.
['Nwafor|Divine C|DC|', 'Chakraborty|Sreeparna|S|', 'Jun|Sujung|S|', 'Brichacek|Allison L|AL|', 'Dransfeld|Margaret|M|', 'Gemoets|Darren E|DE|', 'Dakhlallah|Duaa|D|', 'Brown|Candice M|CM|']
D000544:Alzheimer Disease D000818:Animals D001522:Behavior, Animal D004195:Disease Models, Animal D004734:Energy Metabolism D005260:Female D008124:Locomotion D051379:Mice D008810:Mice, Inbred C57BL D008822:Mice, Transgenic D059225:Nociception D012893:Sleep Wake Disorders D013697:Thermosensing
Metabolism Sleep Sensorimotor Alzheimer’s disease Neuroinflammation